We developed a new, highly specific antibody that localizes y-glutamyl transpeptidase (GGT) in formalin-fd sections of human tissue. The specificity of the antibody, GGT129, is demonstrated by immunostained Westem blots of whole cell homogenate from five Merent tissues. The utility of the antibody is shown by a comprehensive study of GGT expression in normal human tissue. This study reveals GGT expression for the fmt time in a number of tissues, induding glands in the endocervix, endometrium, and adrenals. Strong immunoreactivity was observed on the surface of renal proximal tubule cells, hepatic bile canaliculi, and capillary endothelial cells within the nervous system. Secretory
Introduction
GGT is a cell surface glycoprotein that cleaves glutathione, glutathione conjugates, and other y-glutamyl compounds (Lieberman et al., 1995; Hanigan and Pitot, 1985) . The function of GGT is most clearly defined in the kidney, where it is localized to the luminal surface of the proximal tubule cells. Renal GGT prevents excretion of glutathione from the body by initiating cleavage of this tripeptide into its constituent amino acids, which can then be reabsorbed (Hanigan and Ricketts, 1993; Curthoys and Hughey, 1979) . The substrates for GGT and the function of the enzyme in other tissues are less well understood.
Determining the function of GGT requires knowledge of its location throughout the body. Many human tissues have never been analyzed for GGT expression. Among tissues that have been analyzed there are conflicting results regarding the localization and level of GGT expression (Shiozawa et al., 1989; Albert et al., 1964; Glenner et al.. 1962; Goldbarg et al., 1960) . To clarify these issues and to provide insight into its function, we have developed an antibody that can be used to immunolocalize GGT in human tissues. or absorptive cells in sweat glands, prostate, salivary gland ducts, bile ducts, panaeatic acini, intestinal crypts, and testicular tubules were also GGT- tively s t a i n e d stromal cells and GGT-positive histiocyte^ me An accurate assessment of GGT expression in human tissues requires an antibody that meets several criteria. The antibody must detect GGT in formalin-fixed sections of human tissues. The antibody must be directed against the peptide backbone of the protein because post-translational modifications of GGT, such as glycosylation and addition of siliac acid, differ between normal and neoplastic tissues (Arai et al., 1992; Yamaguchi et al., 1989) . Finally, the antibody should not detect the inactive form of GGT encoded by the alternatively spliced form of human GGT mRNA that has been detected in liver, kidney, brain, intestine, stomach, placenta, and mammary gland (Pawlak et al., ,1990) . We have prepared an antibody, GGT129, that meets all of these criteria. The antibody is directed against a peptide at the C-terminus of the heavy subunit of GGT. This peptide is not encoded by the alternatively spliced mRNA.
The GGT129 antibody was used to evaluate GGT expression in normal human tissues. The results of this analysis provide a comprehensive overview of GGT expression in human tissues and show for the first time that GGT is expressed in glands in the endocervix, endometrium, and adrenals.
Materials and Methods

Preparation of GGTW Antibody. A 20-amino-acid peptide correspond-
ing to the C-terminus of the heavy subunit of human GGT was synthcsized with an N-terminal cysteine by the Biomolecular Research Facility at The University of Virginia. The sequence of the peptide was CMTHP-ISYYKPEFYTF'DDGG. The peptide was conjugated to KLH by incubating 0.5 mg peptide and 1.0 mg KLH (Sigma; St Louis, MO) in 100 mM sodium phosphate buffer, pH 7.4, containing 0.2% glutaraldehyde for 4 hr at room temperature (RT). The incubation mixture was then dialyzed against PBS. Antibodies to the KLH-conjugated peptide were prepared in New Zealand White Rabbits by HRP (Denver, PA).
Affinity Purifcation. Peptide-specific antibody was purified from the serum of immunized animals by affinity column chromatography. The p e p tide was linked via the sulfhydryl group on cysteine to Sulfolink Gel (Sulfolink Gel Kit #20405; Pierce, Rockford, IL). A second affinity column was prepared with the peptide and Affi-Gel 15 (Bio-Rad; Richmond, CA). After application of the serum, columns were rinsed with PBS containing 0.5 M NaCI. High-affinity antibody was eluted from both columns by lowering the pH to 2.8. Affinity-purified antibody was dialyzed vs PBS and stored at -8O'C in 1% bovine serum albumin. Both columns yielded purified antibody useful for immunohistochemical staining.
Tissue Homogenates. Samples of normal human myometrium, intestinal epithelium, and endometrium were obtained from surgical specimens in the Department of Pathology at the University of Virginia Health Sciences Center. Human liver and kidney were obtained from autopsy material. Tissue was stored at -80°C. Tissue was homogenized with a Potter-Elvehjem homogenizer in PBS at 4'C. The protein concentration in the homogenate was determined by the BCA protein assay (Pierce).
GGT Biochemical Activity. GGT activity in the tissue homogenates and washed human sperm was quantified according to the method of Tateishi and co-workers (1976) . Glycylglycine 40 mM was used as an acceptor. One unit of GGT activity is defined as the amount of enzyme that releases one pmole p-nitroaniline per min at 25°C.
Immunoblotting. Tissue homogenates were diluted to 0.5 mg/ml in 125 mM Tris, pH 6.8. 1% SDS, 5 % P-mercaptoethanol, 10% glycerol, and were boiled for 2 min. Samples (1 pg per lane) were electrophoresed on a 5-20% polyacrylamide-SDS gel and electroblotted to nitrocellulose (0.45pm pore; Schleicher & Schuell, Keene, NH). The blots were blocked overnight at 4°C in 10 mM Tris, pH 8.0, 150 mM NaCI, 0.05% Tween 20 (TBST) containing 5% bovine serum albumin. Blots were rinsed in TBST, then incubated for 2 hr at RT in affinity-purified GGT129 diluted 1:20,000 relative to the serum concentration. Blots were washed in three changes of TBST and incubated for 2 hr with peroxidase-conjugated goat anti-rabbit IgG (Jackson Immunoresearch Laboratories; West Grove, PA) diluted 1:1O, OoO in TBST. After a final rinse in TBST, immunolabeled bands were visualized by enhanced chemiluminescence (BM Chemiluminescence Western Blotting Reagents; Boehringer Mannheim, Indianapolis, IN) according to the manufacturer's directions.
Immunohistochemical Staining for GGT. Five-pm sections from routine zinc formalin-fixed, paraffin-embedded normal tissues were obtained from archival autopsy and surgical pathology blocks at the University of Virginia Health Sciences Center. For immunohistochemical staining, paraffin was removed and the tissue rehydrated with four 10-min incubations in xylene, three 5-min incubations in 100% ethanol, three 5-min incubations in 95% ethanol, and a 5-min wash in distilled water. Endogenous peroxidase activity was inhibited by two 15-min incubations in 0.3% H202 in methanol, followed by two 5-min washes in PBS. Endogenous biotin was blocked with a 15-min incubation in avidin blocking solution (AvididBiotin Block Kit; Vector Laboratories, Burlingame, CA), a 3-min wash in PBS, a 15-min incubation in biotin blocking solution (AvidinlBiotin Block Kit), and a 10-min wash in PBS. Slides were incubated for 10 min in PBS containing 1.5% normal goat serum (Gibco; Grand Island, NY). Affinity-purified GGT129 antibody in 1% bovine serum albumin was diluted in 1.5% goat serum-PBS. The primary antibody was diluted 1:1000 relative to the starting serum concentration. Slides were incubated for45 min in primary antibody. Control slides were incubated in an equivalently diluted solution of 1% bovine serum albumin. The antibody was removed and slides were washed for 3 min in PBS. The slides were incubated with biotinylated anti-rabbit IgG and avidin-linked peroxidase (Vectastain Elite ABC Peroxidase Kit; Vector). Peroxidase was localized with the Biogenex Liquid DAB Substrate Kit (BioGenex; San Ramon, CA). Slides were incubated for 3 min in 0.5% cupric sulfate to fLu the stain, rinsed in deionized water, and counterstained for 3 min in Gill's 3 Hematoxylin (Sigma). All incubations were done at RT. After rinsing the slides were dehydrated with 95% and 100% ethanol and xylene, then coverslipped with Permount. A section of normal human kidney was included as a positive control with each set of sections stained.
Human Sperm. Washed human sperm were obtained from the Human Gametes and Embryo Laboratory at The University of Virginia Health Sciences Center. Sperm were washed free of seminal fluid by pelleting through a two-step Percoll gradient (47.5 and 90% Percoll), then washed with Biggers Whitten and Whittingham medium (Irvine Scientific; Irvine CA) containing 5 mg/ml human serum albumin. Sperm were assayed for GGT activity by the biochemical assay described above. In addition, washed sperm were smeared on a glass slide, air-dried, and stained histochemically for GGT activity as previously described (Hanigan et al., 1994a) .
Results
Western blot analysis of whole tissue homogenates was used to determine the specificity of the GGT129 antibody. GGT was analyzed in human myometrium, intestinal epithelium, endometrium, liver, and kidney. Biochemical assay of GGT activity in the homogenates showed that myometrium had less than 1 U GGT activity/g protein, intestinal epithelium 3.6 -c 0.4 U/g protein, endometrium 7.0 * 0.3 U/g protein, liver 20.7 * 0.9 U/g protein, and kidney 103 -c 2.0 Ulg protein. The homogenates were subjected to SDS-PAGE electrophoresis, blotted, and stained with the GGT129 antibody. A single band at approximately 66 KD, corresponding to the heavy subunit of human GGT, was reactive with the antibody (Figure .I). Among the tissues analyzed, the relative level of GGT activity corresponded to the amount of the heavy subunit detected on the Western blot.
Immunohistochemical staining with the anti-GGT polyclonal antibody revealed that GGT was restricted to specific cell types (Bble 1). The majority of GGT-positive cells were epithelial. In addition, macrophages in many tissues were immunoreactive. Fat and muscle were consistently GGT-negative. Fibrous stroma was generally negative for GGT, but thin bands of immunopositive fibroblasts were seen in some sections of bladder, colon, liver, breast, and ovary.
Concordant with the high levels of GGT activity measured by the biochemical assay, immunohistochemical staining revealed intense positivity of renal proximal tubule cells with localization to the luminal surface ( Figure 2A) . The glomeruli and distal tubules were negative. The transitional epithelium of the bladder and the ureter was negative for GGT. As noted above, in some sections the stroma under the transitional epithelium was positive for GGT (Figure 2B) .
Major and minor salivary gland epithelium showed strong immunohistochemical staining, with localization to the apical surface of salivary ducts. The acini were negative ( Figure 2C ). Bronchial and lung epithelium lacked GGT staining. Alveolar macrophages were weakly GGT-positive. Esophageal squamous epithelium was negative, but duct cells draining the submucosal glands were positive. Analysis of the stomach showed no staining of the surface epithelium, but weak apical staining was observed in some of the antral mucous glands. The duodenum and small intestine had weak positive apical staining of the crypts and very weak positive staining on the intestinal surface. Crypts and epithelium in the colon and appendix were negative. Goblet cells lacked immunoreactivity. Macrophages within the appendix were positive.
In the liver, GGT was localized to the bile canaliculi of the hepatocytes ( Figure 2D ). The staining was most intense in the hepatocytes near the portal areas. The luminal surface of biliary epithelium in both the small and the large ducts was also positive. The apical surface of the gallbladder epithelium was moderately stained. In the pancreas, the acinar cells were strongly positive and apical staining of the duct epithelium was present. Islet cells were completely negative (Figure 2E ).
In the brain and spinal cord, the endothelial cells lining the capillaries showed striking GGT-positivity. The endothelial cells lining arteries were negative, although weak staining was present in the perivascular cells surrounding large arteries. Neurons and glial cells were negative ( Figure 2F) .
Many cells within the male reproductive system showed high levels of GGT immunostaining. In the testis, the Sertoli cells had strong apical membrane immunoreactivity and Leydig cells were moderately positive. An undescended testicle devoid of germ cells was stained for GGT to highlight the Sertoli cells, which stained strongly positive (Figure 3A) . The epithelium lining the epididymis, seminal vesicle, and vas deferens showed high levels of GGT on the apical surface. The luminal surface of the glandular epithelium in the prostate was GGT-positive, although the underlying basal epithelial cells were negative ( Figure 3B ). GGT was present in seminal fluid, making it difficult to ascertain whether germ cells were GGT-positive. Therefore, human sperm washed free of seminal fluid were stained histochemically and assayed biochemically for GGT activity. Sperm were negative for GGT activity with both methods.
The female reproductive tract had less intense GGT-positivity than the male system. Germ cells, surface epithelium, and most stromal cells in the ovary were negative. Leydig cells showed a very weak level of staining. Occasionally, a small group of spindle-shaped stromal cells within the ovary was GGT-positive. The cilia on the epithelium of the Fallopian tubes stained positive. and nonciliated epithelium was weakly stained. Within the uterus there was a mixture of GGT-positive and -negative glands in both the secretory and the proliferative phase of the menstrual cycle. The fluid within the GGT-positive secretory glands was also GGT-positive. Uterine smooth muscle was negative. The squamous epithelium of the cer- vix was negative, whereas the endocervical glands and their luminal secretions had moderate staining intensity at the surface (Figure 3C) . Breast tissue showed variable apical staining of the epithelium of the ducts and ductules (Figure 3D) . Secretions within the positive ductules were also GGT-positive.
Squamous and sebaceous epithelia of the skin, skeletal muscle, cardiac muscle, fat, nerves, and blood vessels were all GGT-negative. Sweat glands (eccrine) show"ed apical immunostaining. In the spleen, some of the connective tissue around arterioles and within the stroma showed GGT-positive staining. Splenic lymphocytes and those within lymph nodes were negative. However, tingible body macro-phages and other histiocytes within lymph nodes were immunoreactive.
In the adrenal gland, the capillary endothelial cells were positive for GGT. The adrenal cortical cells were very weakly immunopositive, unlike the adrenal medullary cells, which were negative. Follicular epithelial cells in the thyroid showed GGT staining, whereas the colloid did not show GGT activity. Staining of parathyroid epithelium was negative.
Placental and fetal tissues were also analyzed for GGT immunoreactivity. Trophoblasts and chorionic villi were negative, whereas cells in the chorionic layer and amnion were moderately GGT-positive. Expression of GGT in fetal tissue was similar to that in adult tissue. In a 12-week-old fetus, the tissue that expressed GGT included proximal tubules in the kidney, bile canaliculi of the hepatocytes, ducts within the pancreas, and the apical surface of the intestinal epithelium ( Figures 3E and 3F) . The adrenal cortex was weakly positive. Tissues that did not express GGT included hematopoietic elements within the liver, skeletal muscle, and cartilage. Gestational endometrium was also positive.
Discussion
The GGT129 antibody was produced against a 20-amino-acid peptide corresponding to the C-terminus of the heavy subunit of human GGT. A Western blot of homogenates of five human tissues showed that the affinity-purified antibody reacted with a single band corresponding to the large subunit of GGT (Shiozawa et al., 1989; Bte and Galbraith, 1987) . The amount of GGT heavy subunit detected on the Western blot correlated with the relative level of GGT activity determined biochemically and by immunohistochemical staining of the corresponding tissues.
Detection of high levels of GGT in the proximal tubules of the kidney by the GGT129 antibody is in agreement with previous studies of GGT expression in humans and rodents (Shiozawa et al., 1989; Rutenburg et al., 1969; Albert et al., 1964) . In the kidney, GGT initiates the cleavage of glutathione into three amino acids which can then be reabsorbed from the glomerular filtrate. In this study we found that GGT is present on the luminal surface of epithelial cells lining many ducts and glands. Our data show that GGT is located on the luminal surface epithelium of sweat ducts, endometrial glands, endocervical glands, prostate gland, and epididymis. In addition, GGT is present in salivary glands, bile ducts, acinar cells in the pancreas, and in the crypts of the intestine. Immunolocalization of GGT in the salivary gland is in agreement with results reported by Shiozawa and co-workers (Shiozawa et al., 1993) . Previous studies have shown that inhibition of GGT in the kidney causes glutathionuria, which results in loss of amino acids from the body ( Scott and Curthoys, 1987; Griffith and Meister, 1979) . The presence of GGT in extrarenal tissues may be a means of preventing loss of glutathione and its constituent amino acids from the body.
In salivary glands, endometrial glands, endocervical glands, prostate, epididymis, pancreas, and bile ducts, GGT was present in luminal fluid. Human tears have also been reported to contain GGT activity (Calderon de la Barca Gazguez et al., 1989) . Analysis of GGT in pancreatic juice revealed that the enzyme is not released in a soluble form. Instead, it is associated with membrane fragments released along with secretory proteins during exocytosis (Battistini et al., 1990) . Under normal conditions serum contains a very low level of GGT. Diseases that disrupt the normal architecture of the liver and pancreas result in dramatic elevation of serum GGT (Rosalki, 1975) . Under pathological conditions the normal duct systems are compromised, resulting in the release of bile or pancreatic juice into the serum rather than into the appropriate lumens Hirata et al., 1984) . GGT and other components of bile or pancreatic juice are then present in the serum. Within the nervous system, endothelial cells in the brain and spinal cord were GGT-positive. Studies of brain capillary endothelial cells in culture have shown that expression of GGT requires contact with glial cells or glial conditioned medium (Mituguchi et al., 1994) . GGT converts leukotriene TC4 (LTC4) to leukotriene TD4 (LTD4). LTc4, the slow-reacting substance of anaphylaxis, is released by mast cells and causes increased permeability of the microvasculature (Orning and Hammarstrom, 1980) . Frey (1993) suggested that conversion of LTC4 to LTD4 by GGT is part of a leukotriene degradation pathway that helps to maintain the integrity of the blood-brain barrier. However, some evidence suggests that LTD4 and LE4 are more active than LTC4 in increasing vasopermeability (Lewis and Austen, 1981) .
No GGT activity was detected in fat or muscle, which is in agreement with other studies (Albert et al., 1964; Goldbarg et al., 1960) . Most other stromal cells did not express GGT However, in the testis and ovary Sertoli and Leydig cells were GGT-positive. In the spleen, connective tissue surrounding the arterioles and thin bands of fibrous stroma around the follicles were GGT-positive. Areas of GGT-positive stromal cells were occasionally observed in reproductive tissues, bladder, colon, and liver. The function of GGT in these cells is unclear. GGT was especially conspicuous in macrophages of the appendix, lymph nodes, and lung, but the function of the enzyme in these cells is uncertain.
The data in this study indicate that regulation of GGT during development differs significantly between human and rodent species. In rats, GGT is expressed in fetal liver but is not expressed in the kidney before birth. During the first 3 weeks after birth the level of GGT expression in the liver drops precipitously, whereas GGT levels in the kidney rise dramatically (Wapnir et al., 1982) . Our data indicate that this phenomenon does not occur in humans. Kidney tissue from a 12-week-old fetus .showed intense immunostaining of the proximal tubules, and the fetal liver showed staining of the bile canaliculi. We observed this same pattern of GGT expression in an 11-month-old child and in adult liver and kidney.
The GGT129 antibody allows study of GGT in fixed human tissues. All tissues analyzed in this study were fixed in zinc formalin, which is the routine &cation method for tissue processed by the Surgical Pathology Department at the University of Virginia Health Science Center. Recently, we have obtained formalin-fixed tissue from other institutions at which zinc is not added to the formalin. Staining of these tissues with the GGT129 antibody was equivalent to the staining seen in this study (unpublished data). Therefore, the GGT129 antibody has broad application for immunohistochemical detection of GGT in routine formalin-fixed tissue.
Many human tumors express high levels of y-glutamyl transpeptidase (GGT) (Hanigan et al., 1994a; Levine et al., 1983; Dempo et al., 1981) . There is widespread interest in the role of this enzyme in tumor formation and tumor response to chemotherapy. Studies of tumor development in hepatocarcinogen-treated rats have shown that induction of GGT is one of the earliest markers of preneoplastic liver cells (Goldsworthy et al., 1986) . GGT can provide a selective growth advantage to tumor cells by cleaving serum glutathione and thereby providing cells with a secondary source of cysteine (Hanigan, 1995) . GGT may also be critical to the effectiveness of chemotherapeutic agents by affecting the intracellular glutathione levels and by initiating the further metabolism of glutathioneconjugated drugs (Ahmad et al., 1987; Elfarra and Anders, 1984) . Induction of GGT activity and increased intracellular glutathione concentrations have been correlated with increased resistance of tumors to chemotherapeutic drugs (Godwin et al., 1992; Lau et al., 1991; Lewis et al., 1988) . In contrast, cisplatin and a series of halogenated hydrocarbons require GGT activity in the kidney to be converted to nephrotoxins (Dekant et al., 1995; Hanigan et al., 1994b) . We are analyzing the distribution of GGT in human tumors with the GGT129 antibody and examining the relationship between GGT expression and the response of tumors to chemotherapy. The GGT129 antibody will be useful in furthering the understanding of the role of this enzyme in both normal and neoplastic tissues.
